Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Journal of Alzheimer'S Disease : JAD
|
January 23, 2023
The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators
Hans J Moebius, Kevin J Church
Behavioural Brain Research
|
May 1, 1996
CGP 36,742, an orally active GABAB receptor antagonist, facilitates memory in a social recognition test in rats
C Mondadori, H J Moebius, M Zingg
Hamostaseologie
|
October 17, 2007
[Functional proteome analysis of human platelets]
U Lewandrowski, R P Zahedi, J Moebius, et al.
Alzheimer'S Research & Therapy
|
June 9, 2025
Deuteration may reduce the efficacy of dextromethorphan in treating agitation in Alzheimer's disease
Anton Bespalov, Jina Swartz, Nadine Knowles, et al.
Neural Plasticity
|
November 18, 2022
Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential
John Olichney, Jiangyi Xia, Kevin J Church, et al.
Life Sciences
|
March 29, 2000
No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use
G L Wenk, G Quack, H J Moebius, et al.
Journal of Geriatric Psychiatry and Neurology
|
May 13, 2025
A Descriptive Statistical Analysis of Neuropsychiatric Symptom Pair Prevalence
Timofey L Galankin, Jina Swartz, Hans J Moebius, et al.
Stroke
|
October 2, 2014
Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke
Roman Urfer, Hans J Moebius, David Skoloudik, et al.
Journal of Alzheimer'S Disease : JAD
|
February 18, 2022
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial
Xue Hua, Kevin Church, William Walker, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 20, 2015
Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
Richard S E Keefe, Herbert A Meltzer, Nancy Dgetluck, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Journal of Alzheimer'S Disease : JAD
|
January 23, 2023
The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators
Hans J Moebius, Kevin J Church
Behavioural Brain Research
|
May 1, 1996
CGP 36,742, an orally active GABAB receptor antagonist, facilitates memory in a social recognition test in rats
C Mondadori, H J Moebius, M Zingg
Hamostaseologie
|
October 17, 2007
[Functional proteome analysis of human platelets]
U Lewandrowski, R P Zahedi, J Moebius, et al.
Alzheimer'S Research & Therapy
|
June 9, 2025
Deuteration may reduce the efficacy of dextromethorphan in treating agitation in Alzheimer's disease
Anton Bespalov, Jina Swartz, Nadine Knowles, et al.
Neural Plasticity
|
November 18, 2022
Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential
John Olichney, Jiangyi Xia, Kevin J Church, et al.
Life Sciences
|
March 29, 2000
No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use
G L Wenk, G Quack, H J Moebius, et al.
Journal of Geriatric Psychiatry and Neurology
|
May 13, 2025
A Descriptive Statistical Analysis of Neuropsychiatric Symptom Pair Prevalence
Timofey L Galankin, Jina Swartz, Hans J Moebius, et al.
Stroke
|
October 2, 2014
Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke
Roman Urfer, Hans J Moebius, David Skoloudik, et al.
Journal of Alzheimer'S Disease : JAD
|
February 18, 2022
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial
Xue Hua, Kevin Church, William Walker, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 20, 2015
Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
Richard S E Keefe, Herbert A Meltzer, Nancy Dgetluck, et al.
Page
of 3